Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
The DIPG/DMG National Tumor Board: The power of advocacy.
Journal: Neuro-oncology pediatrics
Published: August 06, 2026
Immunotherapy for Diffuse Midline Glioma: From Preclinical Modeling to Clinical Translation.
Journal: Cancers
Published: June 02, 2026
Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03.
Journal: Neuro-oncology practice
Published: March 09, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 01, 2026
Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial.
Journal: Neuro-oncology
Published: December 18, 2025
Translational advancement of immunotherapeutics against pediatric central nervous system tumors.
Journal: Advances in cancer research
Published: November 06, 2025
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma.
Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025
A Cavernous Sinus Meningioma in a Child with Progressive Bilateral Visual Loss Ultimately Attributed to Unsuspected Optic Nerve Sheath Meningiomas.
Journal: Case reports in ophthalmology
Published: July 31, 2025
Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review.
Journal: Journal of neuro-oncology
Published: July 28, 2025
Children with medulloblastoma treated with modified ACNS0821 temozolomide, irinotecan, and bevacizumab: The Seattle Children's Hospital experience.
Journal: Neuro-oncology practice
Published: June 09, 2025
Last Updated: 09/26/2026